These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan. Chang YH; Pearson CM; Chedid L J Exp Med; 1981 Apr; 153(4):1021-6. PubMed ID: 6972989 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant activity of N-acetyl muramyl dipeptides for the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs. Azuma I; Kamisango KI; Saiki I; Tanio Y; Kobayashi S; Yamamura Y Infect Immun; 1980 Sep; 29(3):1193-6. PubMed ID: 7429634 [TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of polyriboinosinic acid:polyribocytidylic acid and either bacterial peptidoglycans or synthetic N-acetylmuramyl peptides on production of adjuvant-induced arthritis in rats. Kohashi O; Kotani S; Shiba T; Ozawa A Infect Immun; 1979 Nov; 26(2):690-7. PubMed ID: 546792 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant activity of 6-O-mycoloyl derivatives of N-acetylmuramyl-L-seryl-D-isoglutamine and related compounds in mice and guinea pigs. Uemiya M; Sugimura K; Kusama T; Saiki I; Yamawaki M; Azuma I; Yamamura Y Infect Immun; 1979 Apr; 24(1):83-9. PubMed ID: 313372 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant activity of mycoloyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in mice and guinea pigs. Uemiya M; Saiki I; Kusama T; Azuma I; Yamamura Y Microbiol Immunol; 1979; 23(8):821-3. PubMed ID: 120487 [No Abstract] [Full Text] [Related]
8. Higher immunoadjuvant activities of N-acetyl-beta-D-glucosaminyl-(1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine in comparison with N-acetylmuramyl-L-alanyl-D-isoglutamine. Tsujimoto M; Kinoshita F; Okunaga T; Kotani S; Kusumoto S; Yamamoto K; Shiba T Microbiol Immunol; 1979; 23(9):933-6. PubMed ID: 576117 [No Abstract] [Full Text] [Related]
9. Arthritis-inducing ability of a synthetic adjuvant, N-acetylmuramyl peptides, and bacterial disaccharide peptides related to different oil vehicles and their composition. Kohashi O; Tanaka A; Kotani S; Shiba T; Kusumoto S; Yokogawa K; Kawata S; Ozawa A Infect Immun; 1980 Jul; 29(1):70-5. PubMed ID: 7399708 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant activity of carbohydrate analogs of N-acetylmuramyl-L-alanyl-D-isoglutamine on the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs. Azuma I; Okumura H; Saiki I; Kiso M; Hasegawa A; Tanio Y; Yamamura Y Infect Immun; 1981 Sep; 33(3):834-9. PubMed ID: 7287186 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs. Chedid L; Parant M; Parant F; Lefrancher P; Choay J; Lederer E Proc Natl Acad Sci U S A; 1977 May; 74(5):2089-93. PubMed ID: 325566 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant activities in production of reaginic antibody by bacterial cell wall peptidoglycan or synthetic N-acetylmuramyl dipeptides in mice. Ohkuni H; Norose Y; Ohta M; Hayama M; Kimura Y; Tsujimoto M; Kotani S; Shiba T; Kusumoto S; Yokogawa K; Kawata S Infect Immun; 1979 May; 24(2):313-8. PubMed ID: 457277 [TBL] [Abstract][Full Text] [Related]
13. Correlation between the immunoadjuvant activities and pyrogenicities of synthetic N-acetylmuramyl-peptides or -amino acids. Kotani S; Watanabe Y; Shimono T; Harada K; Shiba T Biken J; 1976 Mar; 19(1):9-13. PubMed ID: 779765 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds. Azuma I; Sugimura K; Yamawaki M; Uemiya M; Kusumoto S; Okada S; Shiba T; Yamamura Y Infect Immun; 1978 Jun; 20(3):600-7. PubMed ID: 97234 [TBL] [Abstract][Full Text] [Related]
15. Immunoadjuvant activities of cell walls, their water-soluble fractions and peptidoglycan subunits, prepared from various gram-positive bacteria, and of synthetic n-acetylmuramyl peptides. Kotani S; Watanabe Y; Shimono T; Narita T; Kato K Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):302-19. PubMed ID: 126564 [TBL] [Abstract][Full Text] [Related]
16. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats. Kohashi O; Kohashi Y; Shigematsu N; Ozawa A; Kotani S Lab Invest; 1986 Sep; 55(3):337-46. PubMed ID: 3489128 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant activity of 6-O-mycoloyl-N-acetylmuramuyl-L-alanyl-D-isoglutamine. Yamamura Y; Azuma I; Sugimura K; Yamawaki M; Uemiya M Gan; 1976 Dec; 67(6):867-77. PubMed ID: 828599 [TBL] [Abstract][Full Text] [Related]
18. Chemical synthesis and adjuvant activity of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) analogs 1, 2. Kamisango K; Saiki I; Tanio Y; Kobayashi S; Fukuda T; Sekikawa I; Azuma I; Yamamura Y Chem Pharm Bull (Tokyo); 1981 Jun; 29(6):1644-54. PubMed ID: 7296716 [No Abstract] [Full Text] [Related]
19. Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes. Kotani S; Kinoshita F; Morisaki I; Shimono T; Okunaga T; Takada H; Tsujimoto M; Watanabe Y; Kato K; Shiba T; Kusumoto S; Okada S Biken J; 1977 Dec; 20(3-4):95-103. PubMed ID: 614856 [TBL] [Abstract][Full Text] [Related]
20. Contractile effects of bacterial cell walls, their enzymatic digests, and muramyl dipeptides on ileal strips from guinea pigs. Ogawa T; Kotani S; Tsujimoto M; Kusumoto S; Shiba T; Kawata S; Yokogawa K Infect Immun; 1982 Feb; 35(2):612-9. PubMed ID: 7056578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]